IASIS PHARMA is a Greek Pharmaceutical Company active in the Production, R&D, Export and Trade of Pharmaceutical Products, Medical Devices and Cosmetics, with special focus on niche market therapeutic categories. IASIS PHARMA manufacturing facilities have been into operation since 1985. They have been renovated and upgraded twice according to Greek and EU Legislations, operating under the strictest GMP, GLP and GDP regulations. In 2012 the manufacturing plant has expanded with the addition of a new automatic production and packaging line for effervescent tablets. In 2016 IASIS PHARMA went ahead to acquire a new property in Attica where it now has under construction new Production Facilities, a Logistics & Distribution Center as well as a Research & Development Center. IASIS PHARMA is one of the major suppliers of the Greek Pharmaceutical market with high quality products, having a strong export operation, supplying EU, other European Countries, Middle East and North Africa with branded and/or private label medicinal and OTC products.